The Genitourinary (GU) Cancer Program at Penn Medicine provides treatment for cancers of the genitourinary (GU) tract including bladder cancer, prostate cancer, kidney cancer, testicular cancer and certain rare tumors.
Penn Medicine has one of the largest and most experienced testicular cancer programs in the United States. Penn faculty have been instrumental in developing chemotherapy treatments for a variety of GU cancers.
A Multidisciplinary Approach to Care
Cancer specialists within the GU Cancer Program have dedicated their clinical and research careers to improving the ability to diagnose and treat GU cancer.
Penn hematologists/oncologists are part of multidisciplinary teams of specialists, including urologists, radiation and surgical oncologists, pathologists and radiologists who are all trained to treat the entire person – not just the disease.
At Penn Medicine, patients with GU cancer benefit from services and programs offered through the Abramson Cancer Center, including nutrition, psychosocial counseling, support groups and education.
Genitourinary (GU) Cancer Services
Hematology/oncology services for bladder cancer, prostate cancer, kidney cancer, testicular cancer, and other rare tumors within the GU Cancer Program include:
- Treatment and disease management
- Follow-up care
- Survivorship programs